Previous 10 | Next 10 |
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2020 Earnings Conference Call May 07, 2020, 05:00 PM ET Company Participants Dan Dischner - VP of Corporate Communications Tony Marrs - VP of Clinical Research William Peters - CFO, Treasurer & Senior VP of Finance Conference Call ...
Image source: The Motley Fool. Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q1 2020 Earnings Call May 7, 2020 , 5:00 p.m. ET Operator Continue reading
Amphastar Pharmaceuticals (NASDAQ: AMPH ): Q1 Non-GAAP EPS of $0.17 beats by $0.08 ; GAAP EPS of $0.08. More news on: Amphastar Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
RANCHO CUCAMONGA, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended March 31, 2020. First Quarter Highlights Net revenues of $84.7 milli...
RANCHO CUCAMONGA, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its first quarter of 2020 ended March 31, 2020, after the market closes on Thursday, May 7th, 2020, and will hold a conference call t...
The FDA approves Amphastar Pharmaceuticals' (NASDAQ: AMPH ) marketing application for emergency allergic reaction med Epinephrine Injection, USP 30 mg/30mL (1 mg/mL) Multiple Dose Vial, a generic version of Adrenalin ® (Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose...
RANCHO CUCAMONGA, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) (“Amphastar”), today announces that the U.S. Food and Drug Administration (“FDA”) has granted approval of its Abbreviated New Drug Application (...
Amphastar Pharmaceuticals (NASDAQ: AMPH ) announces that Mr. Jason B. Shandell has stepped down as President, General Counsel, and member of the Board of Directors, effective April 10. More news on: Amphastar Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
RANCHO CUCAMONGA, Calif., April 13, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”), a California-based, specialty, generic pharmaceutical company, today announces a recent simplification of the Companyȁ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...